MarginsXMarginsX
Home › Markets › Health Care › ATHE

Alterity Therapeutics Limited (ATHE)

ATHE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.96
0.00% on the day
Market cap
$35.7M
Nano cap
Revenue
No annual revenue filed since the period ending 2018-06-30
Net income
No annual revenue filed since the period ending 2018-06-30

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerATHE on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryAustralia
IPO yearNot reported by the screener
SEC CIK0001131343
SEC industry codePharmaceutical Preparations
Incorporated inAustralia

Financials

No annual revenue filed since the period ending 2018-06-30.

Warning signs

Cash runway
19.9 months
37.3M AUD cash at June 30, 2026
Share count, 1 year
See the dilution note
Going-concern doubt
No
20-F filed August 28, 2026
Insider net buying, 12 months
$24K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-08-28
Cash and burn37.3M AUD cash; operating cash flow -5.6M AUD a quarter.Report 2026-06-30
Shares outstanding18,125,739 (2026-06-30); 760,614,224 a year earlier; 203,324,802 three years earlier. share count fell by more than half since 2025-06-30 with no split on record, which usually means a reverse split; 1y dilution not computed; share count fell by more than half since 2023-06-30 with no split on record, which usually means a reverse split; 3y dilution not computed.Cover page 2026-06-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers, Melbourne, AustraliaPCAOB Form AP 2026-09-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $24K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-06-30
Not filed-23.4M AUD-22.5M AUD37.3M AUDNo debt tagsNeeds four quarters20-F 2026-08-28
FY 2025
2025-06-30
Not filed-12.1M AUD-11.5M AUD33.2M AUDNo debt tagsNeeds four quarters20-F 2025-08-29
FY 2024
2024-06-30
Not filed-19.1M AUD-12.6M AUD12.6M AUDNo debt tagsNeeds four quarters20-F 2025-08-29
FY 2023
2023-06-30
Not filed13.8M AUD-20.0M AUD15.8M AUDNo debt tagsNeeds four quarters20-F 2023-08-31
FY 2022
2022-06-30
Not filed12.8M AUD-12.3M AUD34.8M AUDNo debt tagsNeeds four quarters20-F 2023-08-31
FY 2021
2021-06-30
Not filed15.3M AUD-17.3M AUD28.1M AUDNo debt tagsNeeds four quarters20-F 2023-08-31
FY 2020
2020-06-30
Not filed13.5M AUD-9.4M AUD9.2M AUDNo debt tagsNeeds four quarters20-F 2022-08-31
FY 2019
2019-06-30
Not filed12.3M AUD-14.0M AUD14.4M AUDNo debt tagsNeeds four quarters20-F 2021-09-02

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in AUD.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
PROSPECTUS SUPPLEMENT
424B52024-02-15
Latest annual report
FORM 20-F
20-F2026-08-28
Latest quarterly / interim
FORM 6-K
6-K2026-11-12

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-19.3%
1 month-31.2%
3 months-58.3%
Year to date-36.4%
1 year-46.9%
From 52-week high-66.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
VERUVeru Inc.$2.08-0.48%$35.5M
TELOTelomir Pharmaceuticals Inc.$0.4810-1.96%$35.4M
OSTXOS Therapies Incorporated$0.6807-8.63%$35.4M
GRCEGrace Therapeutics Inc.$1.75-3.31%$36.8M
RNTXRein Therapeutics Inc.$0.4000-27.55%$34.5M
SERSerina Therapeutics Inc.$1.42+2.16%$37.7M
BMEABiomea Fusion Inc.$0.5201-10.67%$37.8M
HYPDHyperion DeFi Inc.$2.47-4.26%$38.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier